Triad Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.86M Buy
12,769
+499
+4% +$69K 0.1% 134
2026
Q2
$1.57M Buy
12,270
+5,584
+84% +$654K 0.09% 149
2026
Q1
$804K Buy
6,686
+851
+15% +$98.2K 0.06% 200
2025
Q4
$614K Buy
5,835
+1,068
+22% +$100K 0.06% 224
2025
Q3
$400K Buy
4,767
+996
+26% +$82K 0.05% 238
2025
Q2
$299K Sell
3,771
-161
-4% -$12.8K 0.06% 217
2025
Q1
$353K Buy
3,932
+116
+3% +$10.8K 0.11% 138
2024
Q4
$380K Buy
+3,816
New +$393K 0.14% 115
2024
Q3
– Sell
-2,593
Closed -$321K – 581
2024
Q2
$321K Buy
2,593
+548
+27% +$70.6K 0.17% 60
2024
Q1
$270K Buy
+2,045
New +$252K 0.21% 47

Other funds holding MRK

Triad Wealth Partners's MRK Position: Q3 2026 in Review

Triad Wealth Partners increased its Merck (MRK) stake by 4.1% in Q3 2026, buying an estimated $69K and bringing the position to 12,769 shares worth $1.86M. The position accounts for 0.1% of the portfolio, ranked #134.

Triad Wealth Partners first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Triad Wealth Partners held 12,769 shares of Merck worth $1.86M as of Q3 2026.
  • Triad Wealth Partners bought 499 Merck shares in Q3 2026, an estimated $69K.
  • Merck made up 0.1% of Triad Wealth Partners's portfolio in Q3 2026, its #134 holding.
  • Triad Wealth Partners first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.